1-3 of 3
Carmen Fernández
Close
Sort by
Journal Articles

Treatment of High-Risk (HR) Philadelphia Chromosome-Negative (Ph-) Adult Acute Lymphoblastic Leukemia (ALL) According to Classical Risk Factors and Minimal Residual Disease (MRD). Interim Results of the PETHEMA ALL-AR-03 Trial.

Josep Ribera, MD, Albert Oriol, MD, Mireia Morgades, MD, Josep Sarrá, MD, Salut Brunet, MD, Andreu Llorente, MD, Ramon Guardia, MD, Ricardo Parody, MD, Teresa Bernal, MD, Jordi Esteve, MD, Miguel Sanz, MD, Eloy Del Potro, MD, Juan Bergua, MD, Maria-Jose Moreno, MD, Carlos Grande, MD, Javier Bueno, MD, Antonia Cladera, MD, María-Carmen Fernández, MD, Raimundo García-Boyero, MD, Arancha Bermúdez, MD, Evarist Feliu, MD
Journal: Blood
Blood (2006) 108 (11): 1872.
https://doi.org/10.1182/blood.V108.11.1872.1872
Published: 2006
Journal Articles

Wiskott-Aldrich syndrome protein deficiency leads to reduced B-cell adhesion, migration, and homing, and a delayed humoral immune response

Lisa Westerberg, Malin Larsson, Samantha J. Hardy, Carmen Fernández, Adrian J. Thrasher, Eva Severinson
Journal: Blood
Blood (2005) 105 (3): 1144–1152.
https://doi.org/10.1182/blood-2004-03-1003
Published: 2005
Journal Articles

The Influence of Body Weight on Clinical Outcome of Patients with Venous Thromboembolism: Findings from a Prospective Registry (RIETE).

Manuel Monreal, Raquel Barba, Javier Marco, Helena Martín-Alvarez, Pilar Rondon, Carmen Fernández-Capitan, Fernando Garcia-Bragado, the RIETE Investigators
Journal: Blood
Blood (2004) 104 (11): 1773.
https://doi.org/10.1182/blood.V104.11.1773.1773
Published: 2004